Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela George

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Medical Genetics|October 21, 2024
Lynch syndrome diagnostic testing pathways in endometrial cancers: a nationwide English registry-based studyLucy Loong, Catherine Huntley, Joanna Pethick, et al.
British Journal of Cancer|September 30, 2024
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialBethany Torr, Christopher Jones, Grace Kavanaugh, et al.
Journal of Medical Genetics|July 22, 2022
A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilotBethany Torr, Christopher Jones, Subin Choi, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 13, 2024
British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024Esther Moss, Alexandra Taylor, Adrian Andreou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 18, 2023
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational studyRobert D Morgan, Andrew R Clamp, Bethany M Barnes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 22, 2025
Evaluating the return of additional findings from the 100,000 Genomes Project: A mixed methods study exploring participant experiences of receiving secondary findings from genomic sequencingBethany Stafford-Smith, Morgan Daniel, Michelle Peter, et al.
Eclinicalmedicine|June 24, 2026
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UKRobert D Morgan, Catharine Porter, Cong Zhou, et al.
Journal of Medical Genetics|February 2, 2021
Oncologist-led <i>BRCA</i> counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomesSook-Yee Yoon, Siu Wan Wong, Joanna Lim, et al.
Nature Communications|January 18, 2020
A network analysis to identify mediators of germline-driven differences in breast cancer prognosisMaria Escala-Garcia, Jean Abraham, Irene L Andrulis, et al.
British Journal of Cancer|February 22, 2019
Genome-wide association study of germline variants and breast cancer-specific mortalityMaria Escala-Garcia, Qi Guo, Thilo Dörk, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Medical Genetics|October 21, 2024
Lynch syndrome diagnostic testing pathways in endometrial cancers: a nationwide English registry-based studyLucy Loong, Catherine Huntley, Joanna Pethick, et al.
British Journal of Cancer|September 30, 2024
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialBethany Torr, Christopher Jones, Grace Kavanaugh, et al.
Journal of Medical Genetics|July 22, 2022
A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilotBethany Torr, Christopher Jones, Subin Choi, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 13, 2024
British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024Esther Moss, Alexandra Taylor, Adrian Andreou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 18, 2023
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational studyRobert D Morgan, Andrew R Clamp, Bethany M Barnes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 22, 2025
Evaluating the return of additional findings from the 100,000 Genomes Project: A mixed methods study exploring participant experiences of receiving secondary findings from genomic sequencingBethany Stafford-Smith, Morgan Daniel, Michelle Peter, et al.
Eclinicalmedicine|June 24, 2026
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UKRobert D Morgan, Catharine Porter, Cong Zhou, et al.
Journal of Medical Genetics|February 2, 2021
Oncologist-led <i>BRCA</i> counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomesSook-Yee Yoon, Siu Wan Wong, Joanna Lim, et al.
Nature Communications|January 18, 2020
A network analysis to identify mediators of germline-driven differences in breast cancer prognosisMaria Escala-Garcia, Jean Abraham, Irene L Andrulis, et al.
British Journal of Cancer|February 22, 2019
Genome-wide association study of germline variants and breast cancer-specific mortalityMaria Escala-Garcia, Qi Guo, Thilo Dörk, et al.
Pageof 5